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Abstract
Acute viral wheeze in children is a major cause of hospitalisation and a major risk factor for
the development of asthma. However, the role of the respiratory tract microbiome in the
development of acute wheeze is unclear. To investigate whether severe wheezing episodes
in children are associated with bacterial dysbiosis in the respiratory tract, oropharyngeal
swabs were collected from 109 children with acute wheezing attending the only tertiary paedi-
atric hospital in Perth, Australia. The bacterial community from these samples was explored
using next generation sequencing and compared to samples from 75 non-wheezing controls.
No significant difference in bacterial diversity was observed between samples from those
with wheeze and healthy controls. Within the wheezing group, attendance at kindergarten or
preschool was however, associated with increased bacterial diversity. Rhinovirus (RV) infec-
tion did not have a significant effect on bacterial community composition. A significant differ-
ence in bacterial richness was observed between children with RV-A and RV-C infection,
however this is likely due to the differences in age group between the patient cohorts. The
bacterial community within the oropharynx was found to be diverse and heterogeneous. Age
and attendance at day care or kindergarten were important factors in driving bacterial diver-
sity. However, wheeze and viral infection were not found to significantly relate to the bacterial
community. Bacterial airway microbiome is highly variable in early life and its role in wheeze
remains less clear than viral influences.
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Introduction
Respiratory infections are a significant cause of morbidity in young children, with over half of
hospitalisations in children under 5 years of age being related to respiratory disease [1]. Evi-
dence suggests that environmental and infectious exposures in early life are a major risk factor
for the development of disease [2, 3], including asthma [4–6].
Acute wheeze is the most common reason for children to present to hospital with between
80–90% of these cases being attributed to viral infection [7, 8]. While a number of respiratory
viruses have been implicated in wheeze the most common are respiratory syncytial virus
(RSV) and rhinovirus (RV)[9]. In infants aged less than one year RSV infections predominate,
but after this RV is also viewed as an important risk factor for acute wheeze [10].
The influence of the respiratory tract bacterial community in the context of wheeze is still
being established. Recent studies in this area have implicated organisms such as Moraxella cat-
arrhalis, Haemophilus influenzae and Staphylococcus aureus in increased rates of wheeze [11,
12]. It has been suggested this may be due to immune modulation by these organisms, in
infants resulting in increased risk of asthma development in later life [13].
Using 16s rRNA gene sequencing of respiratory samples from children presenting to hospi-
tal with acute wheezing, this study aimed to examine whether the bacterial community in the
airways of children with acute respiratory wheeze was altered compared with that of non-
wheezing children. Changes in the bacterial community were also explored to determine if
acute RV infection or species had a significant effect on the airway microbiota.
Methods
Children between 0–16 years were recruited as part of the MAVRIC (Mechanisms of Acute
Viral Respiratory Infection in Children) study on presentation to Princess Margaret Hospi-
tal (PMH) for Children, Perth, Western Australia between January 2004 and January 2014.
Cases and controls were recruited through all seasons, and a questionnaire was adminis-
tered to all subjects to determine symptoms of any current illness, including coryzal symp-
toms, and risk factors, including birth history, postnatal and in utero cigarette smoke
exposure, daycare attendance, atopy and allergy history, diagnoses of acute illness (children
were excluded if they had any chronic illness other than asthma), recent antibiotic use, sys-
temic steroids.
Recurrence data was collected on cases included in the study from birth. Hospital presenta-
tion records were used to determine frequency of respiratory presentations both prior to and
following presentation. Five patterns were determined described as “few”, “persistent”, “multi-
ple A”, “multiple B”, and “atypical”. (See supplemental methods for further definitions).
Cases recruited had acute wheezing illness with no other co-morbid conditions besides
asthma, eczema, or atopy. Controls with no pre-existing chronic disease including chronic
respiratory illness were recruited from four sources: siblings and relatives of cases, PMH
patients (presenting with minor injury/fractured limbs), volunteers from the local community
or day care facilities. A proportion of controls had symptoms of mild acute respiratory infec-
tion but no wheeze. Blood, oropharyngeal (OP) swabs and nasal samples (wash or blow) were
collected from each participant.
Several cases were followed up within 9 months of recruitment and viral, OP swab and
blood samples were repeated at this time.
This study was approved by the PMH for Children, Perth, Western Australia Human ethics
committee (Reference: 1761EP). At least one parent or guardian provided informed written
consent for children, prior to participation in the study.
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Atopy
Skin prick tests were performed to 11 allergens (cow’s milk, whole egg, cat pelt, dog dander,
rye grass, mixed grasses, D. pteronyssinus, D. farinae, cockroach and Aspergillus fumigatus,
Alternaria tenuis), a wheal size�3mm or self-reported allergic reaction to an allergen was
used determined atopy.
Bloods cell counts and cathelicidin measurements
Blood cell counts were determined by PathWest Laboratory Medicine WA (PathWest) at
PMH hospital pathology lab.
Cathelicidin (LL-37) was measured in plasma using a commercially available ELISA kit
(Hycult Biotech).
Viral detection
A nasal blow or wash was collected at recruitment and placed immediately on ice prior to stor-
age at -80˚C. Nasal specimens were typed for RV species using methods previously described
[14] using modified primers [15]. Briefly, a semi-nested RT-PCR with primers that amplify the
260-bp variable region of the 5’ untranslated region of the RV genome was completed. RV-
positive samples were sequenced and assigned an RV strain type and species following
sequence alignment with sequences of the 101 classic serotypes and the 53 newly assigned
genotypes, using ClustalX software (University College Dublin, Dublin, Ireland) [16].
A second aliquot from each nasal specimen was tested for RSV, influenza A and B, parain-
fluenza 1–4, RSV, and human metapneumovirus (hMPV) at PathWest using routine diagnos-
tic methods including PCR [17], direct or indirect fluorescent antibody testing, or
immunofluorescence after cell culture as previously described [18]. Whenever possible, sam-
ples were also tested for enterovirus, coronavirus, and bocavirus.
Bacterial detection
Sterile dry rayon swabs (Copan) were used to sample the soft palate of the oropharynx. Specific
care was made not to contaminate samples with any other part of the mouth. Any swab that
made contact with the tongue or cheek were disposed of and a new swab was performed, for
full details see supplementary materials. Samples were immediately put on ice and stored at
-80˚C.
DNA was extracted from samples utilizing an MPbio FastDNA SPIN Kit for soil as per
manufacturers’ instructions and frozen at -80˚C. Samples were transported on dry ice to Impe-
rial College London, for bacterial analysis.
Quantitative PCR
Total bacterial burden was measured using a SYBR green quantitative PCR assay using the
primers 520F, 5’- AYTGGGYDTAAAGNG and 820R, 5’-TACNVGGGTATCTAATCC, target-
ing the V4 region of the 16S rRNA gene as described in Cuthbertson et al 2017[19]. All reac-
tions were performed in triplicate and included standards and non-template controls on the
ViiA 7 Real-time PCR system (Life Technologies, Paisley, UK) using SYBR Fast qPCR Master
mix (KAPA Biosystems, Wilmington, MA, USA). Standards were generated from near full
length cloned 16S rRNA gene of Vibrio natregens. Plasmids quantified using Quantit picogreen
dsDNA Assay kit (Promega, Madison, USA), samples were then serially diluted 10 fold to
form standards ranging from 1 x 108–1 x 104.
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16S rRNA sequencing
Community analysis was carried out using 16S rRNA gene sequencing. Custom dual barcoded
fusion primers were used to target the previously quantified region of the 16S rRNA gene as
previously described [19]. Each sequencing run contained a PCR negative control and a Mock
community, consisting of 34 16S rRNA gene clones of known bacterial species in equal pro-
portions. Sequencing was carried out using the Illumina MiSeq platform using the Illumina
V2 2x250bp cycle kit. Sequences were submitted to the European nucleotide database, project
number PRJEB32061.
Sequencing analysis
Downstream sequencing analysis was carried out using Quantitative Insights in Microbial
Ecology (QIIME) Version 1.9.0 due to the dual barcoded indexs used in this study. All
sequences were trimmed to 200bp and joined with a minimum of 150bp overlap, a maximum
of 10% mismatch was stipulated. Sequences were then demultiplexed and any phiX reads were
removed, prior to OTU picking using open reference UCLUST OTU picking [20], clustering
at 97% similarity using the Silva reference database (www.arb-silva.de), reads with less that
60% id were discarded and 10% of sequences that failed to id were included for de novo clus-
tering. Representative sequences were picked from the most abundant read in the cluster.
PYNAST [21] was used to align representative sequences before running the nearest alignment
space termination (NAST) algorithm [22]. ChimeraSlayer (http://microbiomeutil.sourceforge.
net/) was used to identify and remove any chimeric sequences. The Ribosomal Database Proj-
ect (RDP) naive Bayesian classifier was used to apply taxonomic identification using Silva 115
NR database. Finally, an OTU biom table was created for further downstream analysis.
Exact sequence variants (ESVs) may in some circumstances improve identification of
microbial taxa, but genomic sequencing of the airway microbiota is at an early stage. In order
to avoid over-splitting of taxa and false inflation of diversity, we have taken the conservative
approach of using OTUs in our analyses rather than amplicon sequence variants.
Statistical analysis
All further analysis was carried out using R version 3.3.2 [23]. Pre-processing and primary
analysis was carried out in Phyloseq [24]. Contamination was removed using Decontam [25].
A minimum threshold of 2,000 reads was applied to all, samples with less than 2,000 reads
were removed from further analysis. All remaining samples were then rarefied to the mini-
mum number of reads present in the data subset.
Non-parametric Wilcoxon sign ranked tests were used to test significant differences
between means. Pearson correlations were used to test the relationship between continuous
clinical variables and diversity measures. Adonis permutational ANOVA was used to investi-
gate changes in community composition while Random forest analysis was used to identify
OTU’s associated with disease.
Results
After removal of sequencing controls and those with less than 2000 reads, a total of 201 sam-
ples were taken forward for analysis, see Table 1 (further information in S1 Table). This
included 109 samples from children with acute wheeze (Fig 1) and paired stable follow-up
samples from 17 of these children. Control samples from 75 children without symptoms of
wheeze were collected, this cohort included children from day-care and siblings of those with
acute wheeze (Fig 1).
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Table 1. Demographic table of acute cases and healthy controls. Data indicates counts for cases (acute wheeze diagnosis) and healthy controls. N indicates the total
number of subjects that information was obtained for each group. Count data is indicted as a count (% positive of N). Continuous data is recorded at median of N (mix–
max). Differences in clinical variables were calculated using Wilcoxon sign rank test, differences in ethnic groups, sampling season an RV type were calculated using Chi-
squared.
Acute Controls Statistical comparison
N All N All p
Female (male) 109 51 (58) 75 38 (36) 0.546
Age (median (Min-Max)) 109 3.83 (0.08–13.93) 75 3.155 (0.8–18.5) 0.344
Gestation period (Min-Max) 109 40 (38–43) 65 39 (35–42.5) 0.095
Ethnic group 0.057
Aboriginal (%) 109 5 (5%) 70 2 (3%)
African/African American (%) 12 (11%) 1 (1%)
Asian/Indian (%) 23 (21%) 16 (21%)
Caucasian (%) 54 (50%) 51 (68%)
Maori (%) 3 (3%) 0
Pacific Islanders/Samoan (%) 2 (2%) 0
PNG (%) 2 (2%) 0
Undetermined (%) 8 (7%) 5 (7%)
Season 0.803
Autum (%) 109 20 (18%) 75 4 (5%)
Spring (%) 18 (16%) 17 (23%)
Summer (%) 3 (3%) 3 (4%)
Winter (%) 68 (62%) 51 (68%)
Diagnosis xs
Asthma exacerbation (%) 109 37 (34%) 27 0 <0.001
Viral wheeze (%) 109 49 (45%) 27 0 <0.001
Bronchiolitis (%) 109 14 (13%) 27 0 0.05
Pneumonia (%) 109 1 (0.9%) 27 0 0.632
URTI (%) 109 94 (86%) 64 29 (45%) <0.001
Atopy (%) 89 54 (61%) 63 21 (33%) <0.001
Severity Zscore (min-max) 85 0.3191 (-2.2306–2.0151) NA
Medication
Systemic steroids (%) 105 76 (72%) 67 0 <0.001
Oxygen (%) 99 45 (45%) NA
Blood counts
Platelets (min-max) 82 295 (105–611) 41 292 (35–655) 0.996
T-cells (min-max) 83 10.5 (3.5–27.9) 41 8.3 (4–13.4) 0.006
Neutrophils (min-max) 83 6.87 (0.47–20.41) 40 3.325 (0.71–8.19) <0.001
Lymphocytes (min-max) 83 1.67 (0.27–8.61) 40 3.74 (1.17–7.94) <0.001
Monocytes (min-max) 83 0.54 (0.275–3.39) 40 0.685 (0.3–2.18) 0.019
Eosinophils (min-max) 83 0.06 (0.015–2.67) 40 0.28 (0–1.42) <0.001
Basophils (min-max) 83 0.01 (0–0.38) 40 0.05 (0–0.18) <0.001
tven1 81 2 (0.8–100.4) NA
O2 Saturation 89 95 (69–99) NA
ll37 60 2.0986 (0.2404–6.7606) NA
Viral infection
RV 109 71 (65%) 75 33 (43.99%) 0.004
RV group 71 0.009
A 26 (37%) 17 (51.51%)
B 3 (4%) 6 (18.18%)
(Continued)
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Comparison of acute wheeze and controls
Samples from 109 children with acute wheeze and 75 control children were compared (Table 1
and Fig 1). No significant difference in alpha diversity was observed between the 2 groups
(Richness, P = 0.363; Shannon-Weiner, P = 0.98; Inverse Simpsons, P = 0.654). Adonis permu-
tational ANOVA revealed a significant difference in Bray-Curtis dissimilarity (R2 = 0.016,
P = 0.003), Fig 2A. However, the variation explained was only 1%, suggesting a relationship
driven by a small number of samples (see S1 Fig).
A random forest model was used to predict wheeze based on OTUs in the bacterial commu-
nity. The predictive power of the model for cases and controls was found to be poor (out of
box (OOB) error rate = 34.24%, p = 0.37), therefore the model results were considered unreli-
able and was not used in further investigation. However, indicator species analysis revealed a
significant association of a single Veillonella OTU with the acute group. DeSeq2 analysis indi-
cated the same Veillonella OTU associated with cases while several Haemophilus OTUs were
found to be associated with controls (S2 Fig)
Clinical variables were investigated to see if they were able to better explain bacterial com-
munity variation within this population. Wilcoxon rank sum test was used to investigate 33
binary variables across all samples (S2 Table). After Bonferroni correction for multiple testing,
only the diagnosis of bronchiolitis was found to show a significant difference in bacterial rich-
ness (p = 0.006), Shannon-Weiner (p = 0.017) and inverse Simpsons (p = 0.062). Significant
differences in Shannon-Weiner and inverse Simpsons were observed in those that required
oxygen and those that had ever attended kindergarten. It was noted, however, that none of the
controls were positive for bronchiolitis or required oxygen. Therefore, this relationship was
further tested in the acute wheeze population. Kruskal-Wallis with Dunns test was used to
Table 1. (Continued)
Acute Controls Statistical comparison
N All N All p
C 40 (56%) 10 (30.3%)
Unknown 2 (3%)
RSV 76 16 (215) 63 2 (3%) 0.002
Adenovirus 76 3 (4%) 63 6 (10%) 0.187
Influenza virus 76 0 (0%) 63 1 (2%) 0.278
Parainfluenza virus 76 1 (1%) 63 2 (3%) 0.459
Corona virus 39 20 (51%) 63 1 (2%) 0.312
Human metapneumovirus 75 4 (5%) 63 0 0.065
Enterovirus 34 3 (9%) 9 3 (33%) 0.066
Bocavirus 5 2 (40%) 51 6 (12%) 0.092
Smoking
Mother smoked ever 108 38 (35%) 75 15 (20%) 0.023
Smoking now 108 18 (17%) 75 2 (3%) 0.003
Smoked when pregnant 106 18 (16%) 75 3 (4%) 0.007
smoked regularly during pregnancy 106 15(14%) 75 1 (1%) 0.003
Anyone smoke in the house? 109 33 (30%) 75 10 (13%) 0.008
Siblings and school
No of Children 107 2 (0–5) 75 2 (0–5) 0.028
No of siblings 108 1 (0–8) 72 0 (0–3) 0.015
Kindergarten 107 52 (49%) 74 18 (24%) 0.001
Pre-school 107 42 (39%) 74 9 (12%) <0.001
https://doi.org/10.1371/journal.pone.0223990.t001
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investigate categorical variables, however no significant results were observed. We did not find
any differences in the microbiota that were attributable to recorded breastfeeding. No data was
available to explore the effect of delivery method in this study.
Pearson’s correlations were used to investigate relationships between 20 continuous vari-
ables and alpha diversity measures (S3 Table). Only bacterial biomass was found to have a
weak significant correlation with bacterial richness. Significant changes in blood counts were
not found to hold up to multiple testing and expected differences in the antimicrobial peptide
cathlecidin were not found.
Adonis permutational ANOVA with 99,999 iterations was used to investigate changes in
community composition with 58 variables. Only bacterial biomass, bronchiolitis diagnosis and
regular attendance at day care were found to be significant (S4 Table).
Bronchiolitis diagnosis was found to show significant reduction in alpha diversity. Due to
the control samples coming from a slightly older population true age matched case controls
Fig 1. Stacked bar plots of cases (acute wheeze) and controls ordered by age. Bacterial biomass and patient demographics are indicated in the plots below. Dark green
indicates yes while pale green indicates no, white boxes indicate NA or missing information.
https://doi.org/10.1371/journal.pone.0223990.g001
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Fig 2. NMDS plots based on Bray-Curtis dissimilarity comparing. A) non-wheezing controls (blue) to acute wheezing children (red), R2 = 0.016. B) Wheezing
children (red) and paired follow-up samples (blue). Numbers indicate paired samples from individual patients and are linked by arrows. Ellipses were added assuming a
multivariate normal distribution.
https://doi.org/10.1371/journal.pone.0223990.g002
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were unable to be compared (wheeze, median = 0.195 (min = 0.08 –max = 1.87), control, 1.38
(0.6–1.91)). However, when the microbiota in children with bronchiolitis were compared to
those closest in age there was a significant reduction in alpha diversity (richness; p = 0.01,
Shannon-Weiner, p = 0.003, inverse Simpsons, p = 0.005) that was not associated with change
in bacterial biomass (p = 0.874). Changes in community composition using Bray-Curtis dis-
similarity were found to explain 9.8% of the variation (p = 0.012), S3 Fig.
Acute wheeze
To explore variation within the group suffering from acute wheeze, this group was examined
as a subset from the whole data set and clinical variables were explored (Fig 1). In the acute
wheeze group, significant decrease in all alpha diversity measures (differences in bacterial
diversity between subjects) were seen with bronchiolitis. Fourteen patients with doctor diag-
nosed bronchiolitis were included in the study, all of these patients were under the age of 2
years. Of those diagnosed, all patients also had wheeze. Nine of the patients were positive for
RSV at the time of sampling, 5 of these were also positive for RV (Fig 1).
A significant increase was observed with attendance at kindergarten (S5 Table). Attendance
at preschool showed a significant increase in bacterial richness (number of OTUs) only. Only
patient age was found to show significant positive correlation with bacterial richness (S6 Table).
In the children with acute wheeze, bacterial biomass was found to explain 8.9% of the varia-
tion in beta diversity (p< 0.001). Bronchiolitis (r2 = 0.042, p< 0.001) and attendance at kin-
dergarten (r2 = 0.052, p< 0.001) were also found to be significant in the acute wheeze dataset
(S7 Table).
Within the 109 children with acute wheeze, 71 were below the age of 5. In the acute wheeze
group, the under 5s bacterial biomass remained a significant driver of bacterial community
composition (r2 = 0.06, p< 0.001). However, no other variables were significant in the youn-
ger cohort.
Kruskal-Wallis was used to investigate wheeze recurrence patterns for the five patterns of
wheeze observed in wheeze cases (S4 Fig). No significant difference in alpha bacterial diversity
was observed within or between any of the above recurrence groups.
Rhinovirus (RV)
Within the participants suffering from acute wheeze, 71 patients had RV infection. RV
strains from two patients were unable to be typed. Twenty-six patients were infected with
RV-A, 3 with RV-B and 40 with RV-C. The sample numbers only allowed comparison of
the bacterial community from patients with RV-A with those with RV-C. No significant dif-
ference in alpha diversity was observed. In the under 5s group, 15 patients had RV-A, 1 had
RV-B and 27 had RV-C. A significant difference in richness (W = 123.5, p-value = 0.039)
was observed between those with RV-A and RV-C, however no differences in diversity were
observed. No significant difference in community composition was observed using adonis
(R2 = 0.039, p = 0.328).
Random forest modelling was unable to identify OTUs associated with viral species
(p = 0.504).
Follow-up samples
Stable follow-up samples were collected from 17 individuals after an acute wheezing episode.
No significant difference in bacterial biomass (V = 44, p-value = 0.132) or alpha diversity (rich-
ness, p = 0.289, Shannon, p = 0.145, Simpson, p = 0.109) was found when comparing paired
samples with Wilcoxon signed rank test.
Viral respiratory infections and the bacterial microbiota in wheezing children
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Between and within sample beta diversity was compared (Fig 2B). Significant differences
between paired samples were observed with 5.8% of the variation explained by time of sam-
pling (p = 0.013), however 57.6% of the variation was explained by individual (p = 0.013).
Discussion
In this cohort of children, we found substantial diversity and heterogeneity in OP microbiota
composition regardless of wheeze status. There were no significant microbiome differences
between acute wheeze cases and non-wheezing controls on alpha diversity measures. Beta
diversity was examined using a Bray-Curtis dissimilarity adonis model and while significant
difference (p = 0.003) was found, only 1.6% of the variance is explained by differences between
cases and controls. Further interrogation with Bray-Curtis dissimilarity hierarchical clustering
(S1 Fig) reveals that the correlation is likely driven by a small number of samples and no pat-
tern was observed between those that had wheeze and those that did not (Fig 2). Overall,
despite cases having an acute wheezing illness serious enough to cause presentation to a chil-
dren’s hospital emergency department, there were no clear differences in the bacterial commu-
nity between cases and controls.
In the small number of cases with matched acute and convalescent samples taken up to 9
months later, we were similarly unable to find differences in alpha diversity between the cases
and follow-up samples. Significant differences in beta diversity were observed between cases
and follow-up samples, however the variation explained was 5.8% compared to within subject
changes which explained 57.6% of the variation. The heterogeneous nature of the microbial
community between patients makes investigation into microbial changes a challenge and sup-
ports the need for large-scale longitudinal investigation into community composition in health
and disease.
Random forest analysis has been used in a number of recent studies to investigate predictive
OTUs in microbiome analysis [26, 27]. In this study, random forest was used to attempt to
identify OTU predictors for wheeze. We found that the variation in the microbial community
observed between these groups was high and this led to low confidence in the predictive power
of the model. Random forest analysis of the bacterial community found bacterial OTUs to be
poor predictors of wheeze. This analysis was also performed to determine if any OTUs were
significantly associated with RV infection or between RV species. Neither model was found to
have strong predictive power and estimated accuracy was low.
Diagnosis with bronchiolitis showed a significant difference in bacterial richness compared
with the entire cohort, however this comprised only a small subset of patients (n = 13). When
those with a diagnosis of bronchiolitis were compared to other cases that wheezed or age
matched control subjects, significant differences in alpha and beta diversity were observed
however this may have been driven by subjects with bronchiolitis being significantly younger
than other groups of subjects. Bacterial diversity was found to be significantly reduced in these
subjects with many patients dominated with Streptococcus sp. Further investigation into the
streptococcal species, which is unable to be elucidated from 16S rRNA sequencing, would be
important in further investigations. Longitudinal studies in young children to determine if low
bacterial diversity in the respiratory tract is a risk factor for or the result of bronchiolitis would
be important for future investigations.
In contrast to our findings, there are a number of studies that show significant differences
in microbiome in relation to viral infections compared to healthy subjects [11, 28–30]. These
studies show haemophilus, streptococcus, moraxella associated with acute respiratory tract
infections and staphylococcus, alloiococcus and corynebacterium in healthy samples. A num-
ber of factors account for the differences we find; firstly, they analyse nasopharyngeal (NP)
Viral respiratory infections and the bacterial microbiota in wheezing children
PLOS ONE | https://doi.org/10.1371/journal.pone.0223990 October 17, 2019 10 / 15
samples compared to the OP samples analysed in our study. A number of studies have shown
that these areas show significantly different bacterial communities, and that OP swabs are a
better proxy for the lower respiratory tract microbiome. There are also age differences between
other cohorts and ours.
Lastly analytical methods to look at the microbiome differ between studies. Analytical
methods for microbiota are slowly being standardised, and much of the analytic techniques
are borrowed from ecological analysis to try and accurately portray biodiversity and differ-
ences. In order to find differences, earlier studies have defaulted to simplistic groupings based
on dominant organisms. However, we have observed that many samples are diverse and with-
out a singular dominant organism. For example, Man et al, comparing those with lower respi-
ratory tract infection and healthy controls, found no difference in alpha diversity, and using
beta diversity measures found, similar to us, very small but significant differences between the
groups (r2 = 0.0031, p =<0.0001) [28]. To find significant differences in species, previous
studies grouped samples based on perceived dominance and not necessarily by a dominance
measure or beta diversity based on hierarchical clustering.
The greater variation in age within our population compared to other studies may have
influenced our ability to find significant differences. Bacterial biomass was found to explain
much of the variation in beta diversity within the acute population. Bacterial biomass was also
found to show a weak positive correlation with age. Age was found to be a key variable in the
analysis of this dataset and this relationship has been demonstrated in previous studies [31].
Age is interrelated with developmental changes in blood cell counts and immune function
[32]. With these considerations, we considered changes in the microbiome while controlling
for age.
A strength of our study is that we extracted blood from patients to examine differences in
blood counts and antimicrobial peptides. However, variation in age in the study resulted in
small and non-significant trends in blood cell counts. Cathelicidin was also examined as a can-
didate innate immunity marker as it has both anti-viral and anti-bacterial activity and lower
levels have been shown to be associated with worsened severity in bronchiolitis [33]. However,
we were unable to find a significant change in the bacterial community with changes in
cathelicidin.
Seasonal influences in the same study location (Perth, Australia) have shown to have limited
effects on microbiome in comprehensive longitudinal studies at least in infants [29]. Risk fac-
tors that are associated with hospitalisation as a result of respiratory infections in early life
include maternal smoking during pregnancy, season of birth, delivery mode and gestational
age[34]. When considered in this cohort of mostly hospitalised wheezing children (96%), these
factors were not found to be significantly associated with bacterial or viral infection suggesting
more work is required to fully understand any potential relationship.
At least one other study exists comparing OP microbiome samples between healthy adult
patients and severe asthmatics showing no significant diversity differences [35]. An abundance
of moraxella is found in prior studies in NP. Hilty et al demonstrate that Moraxella (proteo-
bacteria) exists in oropharynx and may account for differences [36]. OP samples were specifi-
cally chosen as they showed greater representation to lower airway samples at least in stable
patients [36, 37]. Whether acute OP swabs reflect lower airway samples in acute wheeze or
acute viral episodes is still unclear but, interestingly, Man et al did show that intensive care
patients had reasonable similarity between NP samples and lower respiratory tracheal samples
(Bray Curtis similarity p = 0.61), but did find key differences, specifically that staphylococcus,
Corynebacterium, and Dolosigranulum sp. were almost exclusively present in NP samples and
absent from endotracheal aspirates [28].
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The bacterial community in the paediatric population is diverse and heterogeneous. The
wide range of clinical factors tested did not fully explain the wide variation in the bacterial
community in these subjects. Age had a significant influence on both the bacterial community
and blood cell counts in this study and the wide age range within the study population helped
explain some of the variation observed.
The simplest interpretation of our results is that acute wheezing illnesses are driven by viral
infections and that these infections have little influence on the bacterial community during the
acute phase of the illness. However, the heterogeneous nature of the subjects made it difficult
to test for significant associations between clinical variables and the oropharyngeal bacterial
community. Prospective longitudinal investigation of children pre, during and post viral infec-
tion may help identify if the bacterial community is either protective or a risk factor for viral
infection and respiratory wheeze.
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